Stay updated with breaking news from Therapeutics Development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
CONGRESS - House Republicans Still Unable to Elect New Speaker. As of publication of this newsletter, the House has held three roll call votes this week to elect a new...
/PRNewswire/ -- The "Emerging Landscape of Targeted Protein Degradation Therapeutics" report has been added to ResearchAndMarkets.com's offering. Advancing...
– Project ‘NADER’ is intended to span multiplephases, starting from mapping rare diseases in the UAE and wider region through innovative risk assessment algorithms, and moving towards clinical trials with
UAE-based Burjeel Holdings and US-based BridgeBio Pharma have announced a new project to revolutionise the field of early diagnosis and treatment of rare diseases or disorders in the UAE and the region.
Burjeel Holdings, one of the largest healthcare providers in